Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy.

Neurology - 10 Jul 2001

Litvan I, Baker M, Hutton M

Abstract excerpt

Genetic studies have shown that progressive supranuclear palsy (PSP) is associated with inheritance of a specific genotype (H1/H1) in the tau gene. The authors investigated whether the H1/H1 genotype or A0/A0 genotype independently or in conjunction with selected environmental risk factors influences the age at onset, severity, or survival in patients with PSP. Our findings suggest that tau genotyping does not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Aged
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Severity of Illness Index

Share to Supranuclear Palsy, Progressive

Share to Survival Analysis

Share to tau Proteins

Source

Identifiers

PMID: 11445645
DOI: 10.1212/wnl.57.1.138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy.PMID 11445645Read ↗

Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy.Semantic proximity Read ↗

Possible association of the tau H1/H1 genotype with primary progressive aphasia.Semantic proximity Read ↗

Effect of MAPT and APOE on prognosis of progressive supranuclear palsy.Semantic proximity Read ↗

Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.Semantic proximity Read ↗

Progressive supranuclear palsy: earlier age of onset in patients with the tau protein A0/A0 genotype.Semantic proximity Read ↗

The effect of tau genotype on clinical features in FTDP-17.Semantic proximity Read ↗

Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants.Semantic proximity Read ↗

The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.Semantic proximity Read ↗

Update on epidemiological aspects of progressive supranuclear palsy.Semantic proximity Read ↗

Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy.Semantic proximity Read ↗

The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism.Semantic proximity Read ↗

Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.